| Stage | UNH | % of rev | ALHC | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $113B | 100.00% | $1.3B | 100.00% | UNH ×84.37 |
| Gross profit | $22.0B | 19.53% | $1.3B | 100.00% | ALHC +80.5pp |
| Operating income | $6.6B | 5.82% | $42M | 3.15% | UNH +2.7pp |
| Pre-tax income | $5.5B | 4.90% | $38M | 2.83% | UNH +2.1pp |
| Net income | $4.3B | 3.82% | $37M | 2.74% | UNH +1.1pp |
| Stage | UNH | ALHC | Gap · A − B |
|---|---|---|---|
| Revenue | $113B100.00% | $1.3B100.00% | UNH ×84.37 |
| Gross profit | 19.53%$22.0B | 100.00%$1.3B | ALHC +80.5pp |
| Operating income | 5.82%$6.6B | 3.15%$42M | UNH +2.7pp |
| Pre-tax income | 4.90%$5.5B | 2.83%$38M | UNH +2.1pp |
| Net income | 3.82%$4.3B | 2.74%$37M | UNH +1.1pp |
No disclosed counterparties: ALHC.
None